Prostate Clinical Trials Search

Current State: NCT ID:
Return to Map
TitleStateStatusNCT ID
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesNew HampshireRecruitingNCT00079001
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesNew HampshireRecruitingNCT00377156
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerNew HampshireRecruitingNCT00430183
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate CancerNew HampshireRecruitingNCT00567580
Study of Immunotherapy to Treat Advanced Prostate CancerNew HampshireRecruitingNCT00861614
F18PET/CT Versus TC-MDP Scanning to Detect Bone MetsNew HampshireRecruitingNCT00882609
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerNew HampshireRecruitingNCT00936390
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerNew HampshireRecruitingNCT00942331
Study of Abiraterone Acetate in Patients With Advanced Prostate CancerNew HampshireAvailableNCT01217697
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceNew HampshireRecruitingNCT01238172
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerNew HampshireRecruitingNCT00063882
Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyNew HampshireAvailableNCT01606982